Microsoft: Analysts Anticipate Q4 Earnings Per Share Of $2.29

Microsoft (NASDAQ: MSFT) will be reporting its fiscal fourth quarter financials today after markets close. Analysts have a consensus $344 12-month price target on the company, via a total of 52 analysts, with 19 analysts having strong buy ratings. 30 analysts meanwhile have buy ratings and three analysts have hold ratings. The street high sits at a $426 price target, and the lowest target sits at $252.

24 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 24 analysts is $52.39 billion; this number is flat year to date now. The highest revenue estimate is $52.9 billion, while the lowest is $51.74 billion.

Onto EBITDA estimates, there are currently only six analysts who have fourth-quarter EBITDA estimates. The mean is currently $25.1 billion, with this number having been revised downwards from $25.4 billion at the start of the year. Street high is a $25.34 billion EBITDA estimate and the lowest is $24.88 billion.

Analysts estimate that quarterly earnings per share will come in at $2.29, with this number being revised steadily down since the start of the year. Street high is $2.35, and the lowest estimate is $2.24 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

These Mining Stocks Have Huge Upside… But Here’s the Catch | Oct. 19-23 – Weekly Mining Mailbag

Selkirk Copper: Why The PEA Discount?

The Gold & Copper Stocks Everyone Keeps Asking About | Oct. 12-16 – Weekly Mining Mailbag

Recommended

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Krait Critical Minerals Signs Option for Historical Nevada King Antimony Mine

Related News

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

FuboTV Gets Downgraded To Market Perform By BMO Capital Markets, Stock Falls

FuboTV (NYSE: FUBO) has had a fantastic run from $26.59 to $62 since the start...

Wednesday, December 23, 2020, 10:48:00 AM

ReconAfrica: Haywood Resumes Coverage With $12.50 Price Target

On May 17th, ReconAfrica (CVE: RECO) announced that they closed a C$41.4 million bought deal....

Monday, May 31, 2021, 03:56:00 PM

Bank Of America Upgrades Canopy Growth’s Price Target To C$36 From C$30

Last week, Canopy Growth (TSX: WEED) (NASDAQ: CGC) reported its fiscal second quarter 2021 financial...

Wednesday, November 18, 2020, 09:59:00 AM

Aphria: The Analyst Take On Q3 Results

On April 12th, Aphria Inc (TSX: APHA) (NASDAQ: APHA) released its fiscal third quarter results....

Wednesday, April 14, 2021, 04:04:00 PM